Total planned funding: $382,596,719
Allocations
Countries/Regions
| Eswatini | $382,596,719 |
Organizational Types
| Private Contractor | $95,100,133 |
| Unknown | $75,283,079 |
| NGO | $66,263,696 |
| University | $63,830,611 |
| Own Agency | $45,244,576 |
| FBO | $13,230,009 |
| Host Country Government Agency | $12,044,827 |
| Multi-lateral Agency | $8,959,694 |
| Other USG Agency | $2,590,094 |
| Implementing Agency | $50,000 |
Program Areas
| Care | $118,224,318 |
| Treatment | $95,507,378 |
| Prevention | $71,936,198 |
| Governance and Systems | $41,985,239 |
| Testing | $29,316,863 |
| Management and Operations | $25,626,723 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $76,326,672 |
| HBHC: Care: Adult Care and Support | $47,778,844 |
| HKID: Care: Orphans and Vulnerable Children | $39,958,970 |
| HVCT: Testing: HIV Testing and Counseling | $29,316,863 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $27,331,190 |
| HVMS: Management and Operations | $25,626,723 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $22,519,808 |
| HVSI: Strategic Information | $20,947,256 |
| HVTB: Care: TB/HIV | $20,341,809 |
| OHSS: Health Systems Strengthening | $14,918,356 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $10,418,486 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $10,399,743 |
| HTXD: Treatment: ARV Drugs | $10,358,150 |
| PDCS: Care: Pediatric Care and Support | $10,144,695 |
| PDTX: Treatment: Pediatric Treatment | $8,822,556 |
| HLAB: Laboratory Infrastructure | $6,119,627 |
| HMBL: Biomedical Prevention: Blood Safety | $1,266,971 |
| HMIN: Biomedical Prevention: Injection Safety | $0 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Not Available:
$56,973,213
Countries/Regions
Columbia University:
$52,397,235
Countries/Regions
Pact, Inc.:
$43,347,389
Countries/Regions
Chemonics International:
$22,700,973
Countries/Regions